Valneva and Serum Institute end chikungunya vaccine partnership
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
Growing patent filings and tier-2 innovators reflect expanding national research base
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Roche says the move marks a step forward in its digital transformation strategy
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Subscribe To Our Newsletter & Stay Updated